Last reviewed · How we verify

NCT03937505

A Safety and Efficacy Study of IS-001 Injection in Patients Undergoing Robotic Hysterectomy

Completed Phase 2 Last updated 5 August 2021
What this trial tests

Phase 2 trial testing IS-001 in Ureter Injury in 94 participants. Completed in 22 July 2021.

Timeline
28 May 2019
Primary endpoint
8 July 2021
22 July 2021

Quick facts

Lead sponsorIntuitive Surgical
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designsequential
Maskingnone
Primary purposeprevention
Enrollment94
Start date28 May 2019
Primary completion8 July 2021
Estimated completion22 July 2021
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Intuitive Surgical — full company profile →

Who can join

Adults 18 to 75, female only, with Ureter Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the safety and efficacy of intravenous injection of IS-001 to aid in intraoperative ureter structure delineation. Stage A of the study will determine the safe optimal dose and Stage B will determine expanded safety and efficacy for intraoperative ureter structure delineation for the identified optimal dose in study participants.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Fluorescence Image-Guided Surgery - a Perspective on Contrast Agent Development.
    Barth CW, Gibbs SL. · · 2020 · cited 79× · PMID 32255887 · DOI 10.1117/12.2545292

Verify or expand the search:

Other trials of IS-001

Trials testing the same drug.

Other recruiting trials for Ureter Injury

Currently open trials in the same condition.

Other Intuitive Surgical trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03937505.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing